Form 4 for MOH MOLINA HEALTHCARE, INC.
Accepted 2025-03-04 00:00:00 ET · period of report 2025-03-01 · accession 0001179929-25-000034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-04 | 2025-03-01 | MOH | WOYS JAMES | COO | A - Grant | $295.90 | +15.6K | 64.2K | +32% | +$4.61M |
| M | 2025-03-04 | 2025-03-01 | MOH | WOYS JAMES | COO | F - Tax | $301.12 | -5,000 | 58.0K | -8% | -$1.51M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-01 | A | A | 9,316 | $301.12 | 62,998 | D | — | — | (F1) Shares issued in settlement of performance stock units granted on March 1, 2022 based on the Company achievement of three-year average adjusted earnings per share at the 149% vesting level for the 2022 performance stock units. (F2) Represents the closing price of the Issuer's common stock on February 28, 2025. |
| 2 | Common | Common Stock | 2025-03-01 | F | D | 3,401 | $301.12 | 59,597 | D | — | — | (F3) The shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. (F2) Represents the closing price of the Issuer's common stock on February 28, 2025. |
| 3 | Common | Common Stock | 2025-03-01 | F | D | 1,599 | $301.12 | 57,998 | D | — | — | (F4) The shares were applied to the payment of withholding taxes arising in connection with the vesting of 4,643 shares on March 1, 2025. (F2) Represents the closing price of the Issuer's common stock on February 28, 2025. |
| 4 | Common | Common Stock | 2025-03-01 | A | A | 6,248 | $288.12 | 64,246 | D | — | — | (F5) Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. (F6) The volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2025 grant date. (F7) The shares shall vest as follows: The 6,248 newly granted shares shall vest in one-third increments on each of March 1, 2026, March 1, 2027, and March 1, 2028. Additional shares shall vest as follows: 3,254 shares on March 1, 2026; and 1,549 shares on March 1, 2027. The remaining shares are vested. |